Measurement of plasma beta-amyloid levels after glucose loading as diagnostic biomarker for Alzheimer disease
Not Applicable
- Conditions
- Alzheimer's disease
- Registration Number
- JPRN-UMIN000004895
- Lead Sponsor
- Osaka University
- Brief Summary
The plasma levels of baseline blood glucose, plasma insulin, and plasma Abeta were not different between the two groups. However, immediately after glucose loading, a significant increase in plasma Abeta40 and Abeta42 levels was observed in AD patients, whereas a mild decrease in plasma Abeta40 and Abeta42 levels was detected in non-AD dementia patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 21
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with diabetes mellitus
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Plasma beta amyloid levels after glucose loading
- Secondary Outcome Measures
Name Time Method